{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:26:36Z","timestamp":1767857196459,"version":"3.49.0"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Long-acting reversible contraception (LARC) is increasingly used by adolescents and young adults (AYAs). Subsequent to LARC insertion, AYAs are presenting to their primary care providers with LARC concerns. This article seeks to equip primary care clinicians with the tools necessary to assess and manage common LARC-associated side effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Side effects are common with progestin-only LARC, and can precipitate early discontinuation of an otherwise effective, low-maintenance form of contraception. Abnormal uterine bleeding, pelvic pain, acne, and weight change are often cited as progestin-only LARC side effects, yet the causes are poorly understood despite extensive research. While most side effects improve with time, therapeutic interventions are available for patients with undesirable side effects that prefer medical management. Research emphasizes the importance of proper patient counseling and clinical follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Counseling remains essential in the management of LARC-associated side effects. However, options are available to temporarily mitigate such side effects and increase LARC satisfaction. While these therapeutic options are prescribed based on expert opinion, such regimens remain inadequately studied in AYA populations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000930","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T13:01:00Z","timestamp":1594126860000},"page":"461-470","source":"Crossref","is-referenced-by-count":10,"title":["Long-acting reversible contraception side effect management"],"prefix":"10.1097","volume":"32","author":[{"given":"Alexandra J.","family":"Edwards","sequence":"first","affiliation":[{"name":"Division of Adolescent\/Young Adult Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy D.","family":"DiVasta","sequence":"additional","affiliation":[{"name":"Division of Adolescent\/Young Adult Medicine"},{"name":"Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Pitts","sequence":"additional","affiliation":[{"name":"Division of Adolescent\/Young Adult Medicine"},{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children's Hospital"},{"name":"Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/AOG.0000000000002632","article-title":"Adolescents and long-acting reversible contraception: implants and intrauterine devices","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"e1257","DOI":"10.1542\/peds.2014-2300","article-title":"Contraception for adolescents","volume":"134","author":"Ott","year":"2014","journal-title":"Pediatrics"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jpag.2019.04.009","article-title":"International perspectives: IUDs and adolescents","volume":"32","author":"Apter","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R6-20230918","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"e022473","DOI":"10.1136\/bmjopen-2018-022473","article-title":"Ecological study on the use of hormonal contraception, abortions and births among teenagers in the Nordic countries","volume":"8","author":"Hognert","year":"2018","journal-title":"BMJ Open"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jadohealth.2018.05.017","article-title":"Changing patterns of contraceptive use and the decline in rates of pregnancy and birth among U.S adolescents","volume":"63","author":"Lindberg","year":"2018","journal-title":"J Adolesc Health"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/AOG.0b013e31827499bd","article-title":"Continuation of reversible contraception in teenagers and young women","volume":"120","author":"Rosenstock","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/AOG.0b013e31821188ad","article-title":"Continuation and satisfaction of reversible contraception","volume":"117","author":"Peipert","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.contraception.2018.02.001","article-title":"Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction","volume":"97","author":"Hubacher","year":"2018","journal-title":"Contraception"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/03630242.2018.1478363","article-title":"Opportunity, satisfaction, and regret: trying long-acting reversible contraception in a unique scientific circumstance","volume":"59","author":"Burke","year":"2019","journal-title":"Women Health"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.contraception.2016.02.004","article-title":"A phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5\u200amg) in postmenarcheal adolescents","volume":"93","author":"Gemzell-Danielsson","year":"2016","journal-title":"Contraception"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jpag.2019.05.001","article-title":"Trends of contraceptive choices among young women in Inner City Houston","volume":"32","author":"Patel","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/13625187.2019.1666362","article-title":"How do women and healthcare professionals view hormonal long-acting reversible contraception? Results from an international survey","volume":"24","author":"Faustmann","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1016\/S2214-109X(18)30481-9","article-title":"Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries","volume":"7","author":"Ponce de Leon","year":"2019","journal-title":"Lancet Glob Health"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13625187.2018.1535653","article-title":"Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database","volume":"23","author":"Agostini","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpeds.2017.06.053","article-title":"Examining the role of the pediatric emergency department in reducing unintended adolescent pregnancy","volume":"189","author":"Solomon","year":"2017","journal-title":"J Pediatr"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jadohealth.2015.10.016","article-title":"Factors associated with interest in same-day contraception initiation among females in the pediatric emergency department","volume":"58","author":"Miller","year":"2016","journal-title":"J Adolesc Health"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jpag.2019.03.010","article-title":"Barriers and solutions to improve adolescent intrauterine device access","volume":"32","author":"Espey","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/acem.13565","article-title":"A pediatric emergency department intervention to increase contraception initiation among adolescents","volume":"26","author":"Hoehn","year":"2019","journal-title":"Acad Emerg Med"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0009922818805234","article-title":"Improving LARC access for urban adolescents and young adults in the pediatric primary care setting","volume":"58","author":"Onyewuchi","year":"2019","journal-title":"Clin Pediatr (Phila)"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpag.2016.09.001","article-title":"Pediatricians\u2019 attitudes and beliefs about long-acting reversible contraceptives influence counseling","volume":"30","author":"Berlan","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpag.2018.09.008","article-title":"Can pediatricians provide long-acting reversible contraception?","volume":"32","author":"Norris","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.acap.2019.03.009","article-title":"Implementation of recommendations for long-acting contraception among women aged 13 to 18 years in primary care","volume":"19","author":"Arnold Rehring","year":"2019","journal-title":"Acad Pediatr"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jogc.2018.11.027","article-title":"Intrauterine contraception: knowledge and prescribing practices of Canadian healthcare providers","volume":"41","author":"Cook","year":"2019","journal-title":"J Obstet Gynaecol Canada"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"376.e1","DOI":"10.1016\/j.ajog.2018.12.022","article-title":"Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants","volume":"220","author":"Simmons","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jadohealth.2019.02.020","article-title":"Predictors of discontinuation of long-acting reversible contraception before 30 months of use by adolescents and young women","volume":"65","author":"Cohen","year":"2019","journal-title":"J Adolesc Health"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/GCO.0000000000000577","article-title":"Family planning in adolescents","volume":"31","author":"Ganti","year":"2019","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jadohealth.2015.10.254","article-title":"Etonogestrel implants in adolescents: experience, satisfaction, and continuation","volume":"58","author":"Obijuru","year":"2016","journal-title":"J Adolesc Health"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpag.2019.09.003","article-title":"Follow-up care and 6-month continuation rates for long-acting reversible contraceptives in adolescents and young adults: a retrospective chart review","volume":"33","author":"Jones","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jmwh.12925","article-title":"Use of an evidence-based guideline for management of side effects from long-acting reversible contraceptives: a quality improvement report","volume":"64","author":"Jacobson","year":"2019","journal-title":"J Midwifery Womens Health"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.contraception.2010.02.020","article-title":"Attitudes and beliefs about the intrauterine device among teenagers and young women","volume":"82","author":"Fleming","year":"2010","journal-title":"Contraception"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jadohealth.2015.05.001","article-title":"Adolescent experiences with intrauterine devices: a qualitative study","volume":"57","author":"Schmidt","year":"2015","journal-title":"J Adolesc Health"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"586.e1","DOI":"10.1016\/j.ajog.2017.01.036","article-title":"Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration","volume":"216","author":"McNicholas","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.contraception.2017.10.007","article-title":"Pregnancy outcomes associated with extended use of the 52-mg 20\u200a\u03bcg\/day levonorgestrel-releasing intrauterine system beyond 60 months: a chart review of 776 women in Brazil","volume":"97","author":"Bahamondes","year":"2018","journal-title":"Contraception"},{"key":"R39-20230918","first-page":"1","article-title":"U.S. selected practice recommendations for contraceptive use","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jpag.2019.02.121","article-title":"Practical tips for intrauterine device counseling, insertion, and pain relief in adolescents: an update","volume":"32","author":"Hillard","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.contraception.2019.01.002","article-title":"Shared negative experiences of long-acting reversible contraception and their influence on contraceptive decision-making: a multimethods study","volume":"99","author":"Brown","year":"2019","journal-title":"Contraception"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/humrep\/deu089","article-title":"A randomized clinical trial of the effect of intensive versus nonintensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives","volume":"29","author":"Modesto","year":"2014","journal-title":"Hum Reprod"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/13625187.2018.1539164","article-title":"Intrauterine device continuation rates and reasons for discontinuation in a Central European clinic with a high standard of care and ultrasound follow-up: a retrospective cohort study","volume":"23","author":"Bachofner","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/13625187.2018.1449825","article-title":"Bleeding patterns for the Liletta\u00ae levonorgestrel 52\u200amg intrauterine system","volume":"23","author":"Schreiber","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(86)90006-5","article-title":"The analysis of vaginal bleeding patterns induced by fertility regulating methods","volume":"34","author":"Belsey","year":"1986","journal-title":"Contraception"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajog.2016.12.008","article-title":"Unscheduled vaginal bleeding with progestin-only contraceptive use","volume":"216","author":"Zigler","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.contraception.2019.02.004","article-title":"Bleeding and spotting with the levonorgestrel 13.5\u200amg intrauterine system: the impact of insertion timing","volume":"99","author":"Shimoni","year":"2019","journal-title":"Contraception"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.contraception.2017.10.005","article-title":"Amenorrhea rates and predictors during 1 year of levonorgestrel 52\u200amg intrauterine system use","volume":"97","author":"Darney","year":"2018","journal-title":"Contraception"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/humrep\/dev102","article-title":"Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception","volume":"30","author":"Kaislasuo","year":"2015","journal-title":"Hum Reprod"},{"key":"R51-20230918","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ijgo.12962","article-title":"The influence of the levonorgestrel-releasing intrauterine system position on bleeding patterns in reproductive age women","volume":"147","author":"Alves","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/AOG.0000000000001644","article-title":"Clinical challenges of long-acting reversible contraceptive methods","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R53-20230918","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2019.03.044","article-title":"Comparing bleeding patterns for the levonorgestrel 52\u200amg, 19.5\u200amg, and 135\u200amg intrauterine systems","volume":"100","author":"Goldthwaite","year":"2019","journal-title":"Contraception"},{"key":"R54-20230918","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jpag.2017.01.002","article-title":"Heavy menstrual bleeding in adolescents","volume":"30","author":"Haamid","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R55-20230918","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jadohealth.2013.02.003","article-title":"Myths and misconceptions about long-acting reversible contraception (LARC)","volume":"52","author":"Russo","year":"2013","journal-title":"J Adolesc Health"},{"key":"R56-20230918","first-page":"CD002126","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethaby","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R57-20230918","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajog.2018.12.008","article-title":"Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis","volume":"220","author":"Sergison","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R58-20230918","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajog.2019.09.044","article-title":"Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52\u200amg) during the first-year postinsertion: a systematic review and meta-analysis","volume":"222","author":"Maldonado","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R59-20230918","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/humrep\/deu063","article-title":"Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study","volume":"29","author":"Heikinheimo","year":"2014","journal-title":"Hum Reprod"},{"key":"R60-20230918","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.contraception.2019.06.009","article-title":"Tamoxifen for the prevention of unscheduled bleeding in new users of the levonorgestrel 52-mg intrauterine system: a randomized controlled trial","volume":"100","author":"Cohen","year":"2019","journal-title":"Contraception"},{"key":"R61-20230918","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/humrep\/dey296","article-title":"Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control \u2013 a randomized controlled trial","volume":"33","author":"Papaikonomou","year":"2018","journal-title":"Hum Reprod"},{"key":"R62-20230918","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ogc.2015.07.004","article-title":"Therapeutic options for unscheduled bleeding associated with long-acting reversible contraception","volume":"42","author":"Friedlander","year":"2015","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R63-20230918","first-page":"CD006034","article-title":"Nonsteroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use","author":"Grimes","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R64-20230918","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/AOG.0000000000003452","article-title":"Relationship between etonogestrel concentrations and bleeding patterns in contraceptive implant users","volume":"134","author":"Lazorwitz","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R65-20230918","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.contraception.2019.05.017","article-title":"Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use?","volume":"100","author":"Mansour","year":"2019","journal-title":"Contraception"},{"key":"R66-20230918","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/13625187.2019.1666361","article-title":"Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users","volume":"24","author":"Peterson","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R67-20230918","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/AOG.0000000000000974","article-title":"Short-term treatment of bothersome bleeding for etonogestrel implant users using a 14-day oral contraceptive pill regimen: a randomized controlled trial","volume":"126","author":"Guiahi","year":"2015","journal-title":"Obst Gynecol"},{"key":"R68-20230918","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/13625187.2016.1210122","article-title":"Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial","volume":"21","author":"Hou","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R69-20230918","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/jog.14195","article-title":"Management of bleeding irregularities among etonogestrel implant users: is combined oral contraceptives pills or nonsteroidal anti-inflammatory drugs the better option?","volume":"46","author":"Upawi","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"R70-20230918","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.contraception.2018.02.009","article-title":"Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: a proof-of-concept trial","volume":"97","author":"Chen","year":"2018","journal-title":"Contraception"},{"key":"R71-20230918","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jpag.2019.08.004","article-title":"Will it hurt? The intrauterine device insertion experience and long-term acceptability among adolescents and young women","volume":"32","author":"Callahan","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R72-20230918","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jpag.2019.09.006","article-title":"Chlamydia infection among adolescent long-acting reversible contraceptive (LARC) and shorter acting hormonal contraceptive users receiving services at New York City school-based health centers","volume":"33","author":"Mendoza","year":"2020","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R73-20230918","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.contraception.2014.11.012","article-title":"Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial","volume":"91","author":"Bednarek","year":"2015","journal-title":"Contraception"},{"key":"R74-20230918","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2017.09.078","article-title":"Practical management of acne for clinicians: an international consensus from the Global Alliance to Improve Outcomes in Acne","volume":"78","author":"Thiboutot","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R75-20230918","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jaad.2017.12.051","article-title":"Incidence of androgenic dermatologic side effects following placement of a levonorgestrel intrauterine device for menorrhagia: a survey-based study","volume":"79","author":"Lullo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R76-20230918","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMcp1702493","article-title":"Acne vulgaris","volume":"379","author":"Zaenglein","year":"2018","journal-title":"N Engl J Med"},{"key":"R77-20230918","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.contraception.2018.05.009","article-title":"A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement","volume":"98","author":"Bahamondes","year":"2018","journal-title":"Contraception"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:28:49Z","timestamp":1695004129000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000930","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}